4.8 Article

Effects of 3-HAA on HCC by Regulating the Heterogeneous Macrophages-A scRNA-Seq Analysis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments

Daniel J. Zabransky et al.

Summary: The response to immune checkpoint inhibitors in hepatocellular carcinoma (HCC) varies among patients. To better understand the mechanisms of response and resistance, syngeneic mouse models are used to study the complex interactions between cancer cells and nonmalignant cells in the tumor microenvironment. These models reveal the heterogeneity of immune tumor microenvironments and the existence of immunosuppressive pathways. Different models and human HCCs have diverse immune tumor microenvironments, highlighting the importance of using multiple syngeneic HCC models for immune modulation research.

HEPATOLOGY (2023)

Article Multidisciplinary Sciences

A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data

Antonio De Falco et al.

Summary: The authors develop SCEVAN, a variational algorithm for copy number-based clonal structure inference in single-cell RNA-seq data, which can characterize the evolution and heterogeneity in tumors and the microenvironment. SCEVAN can automatically and accurately discriminate between malignant and non-malignant cells, resulting in a practical framework to analyze tumors and their microenvironment.

NATURE COMMUNICATIONS (2023)

Review Immunology

Myeloid cell-targeted therapies for solid tumours

Sangeeta Goswami et al.

Summary: This study describes current therapies that aim to modulate the functional activities of myeloid cell populations in the tumor microenvironment, impacting their recruitment, survival, and activity. Myeloid cells are the most abundant immune components in the tumor microenvironment and have diverse functions. The authors highlight key features of monocyte and macrophage biology as potential targets for cancer therapies and discuss the need for a deeper understanding of myeloid cells to improve clinical outcomes.

NATURE REVIEWS IMMUNOLOGY (2023)

Review Oncology

Harnessing cytokines and chemokines for cancer therapy

David J. Propper et al.

Summary: Cytokines play a crucial role in cancer development and progression. While cytokines have been studied for their therapeutic potential in oncology, clinical trials have shown limited efficacy. However, the advent of immunotherapies and a better understanding of the tumor microenvironment have opened up new possibilities for harnessing cytokine networks in cancer treatment.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Pharmacology & Pharmacy

Mesenchymal stem cell treatment restores liver macrophages homeostasis to alleviate mouse acute liver injury revealed by single-cell analysis

Jiahang Zhou et al.

Summary: Research shows that MSC treatment can effectively alleviate ALI, regulate the functional changes of MoMF in different periods, and serve as immunotherapeutic targets for ALI.

PHARMACOLOGICAL RESEARCH (2022)

Review Immunology

Occurrences and Functions of Ly6Chi and Ly6Clo Macrophages in Health and Disease

Yuan-hui Li et al.

Summary: This review discusses the basic biology of Ly6C(hi) and Ly6C(lo) macrophages, including their origin, differentiation, and phenotypic switching, and their diverse functions in homeostasis and disease. Understanding these cells may provide therapeutic approaches for disease treatment.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis

Ya Li et al.

Summary: STAT3 inhibition induces immunogenic cell death (ICD) of hepatocellular carcinoma (HCC) cells and enhances immune recognition and clearance of the tumor. Furthermore, it reshapes the tumor immune microenvironment and enhances anti-tumor immune responses.

MOLECULAR ONCOLOGY (2022)

Letter Biochemistry & Molecular Biology

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma

Chen Xue et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Oncology

Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer

M. Karayama et al.

Summary: The study found significant differences in tryptophan metabolite levels between patients with non-small cell lung cancer and healthy volunteers, with 3-HAA levels correlating with treatment outcomes. Analysis of 3-HAA values can predict the efficacy of ICIs treatment.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Article Cell Biology

3-hydroxyanthranic acid increases the sensitivity of hepatocellular carcinoma to sorafenib by decreasing tumor cell stemness

Guifang Gan et al.

Summary: The study demonstrates that 3-HAA sensitizes HCC cells to sorafenib by reducing tumor stemness, indicating its potential value as a therapeutic agent for HCC.

CELL DEATH DISCOVERY (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Oncology

TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway

Lei Li et al.

Summary: Tryptophan 2,3-dioxygenase (TDO2) is implicated in the metastasis and invasion of hepatocellular carcinoma (HCC) by promoting epithelial to mesenchymal transition (EMT) through activating the Kyn-AhR pathway. Overexpression of TDO2 is correlated with advanced stage and malignant traits in HCC patients, while knockdown or inhibition of TDO2 suppresses migration and invasion of HCC cells.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Tryptophan and indole metabolism in immune regulation

Alessandra Fiore et al.

Summary: L-tryptophan is an essential amino acid that gives rise to various signaling molecules through complex metabolic pathways, playing important roles in immune cell function and cancer therapy.

CURRENT OPINION IN IMMUNOLOGY (2021)

Article Biotechnology & Applied Microbiology

TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27

Chengpeng Yu et al.

Summary: This study found that low TDO2 expression in hepatocellular carcinoma is associated with poor prognosis and adverse clinical outcomes. TDO2 can restrain the proliferation of HCC cells and induce cell-cycle arrest by upregulating the expression of p21 and p27. These results suggest that TDO2 could be a potential biomarker and therapeutic target for HCC.

BIOMED RESEARCH INTERNATIONAL (2021)

Correction Biochemistry & Molecular Biology

Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway (vol 6, 385, 2021)

Lisha Du et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, Research & Experimental

The kynurenine derivative 3-HAA sensitizes hepatocellular carcinoma to sorafenib by upregulating phosphatases

Guifang Gan et al.

Summary: The study demonstrates that 3-HAA sensitizes HCC cells to sorafenib by upregulating phosphatases, indicating it as a promising molecule for HCC therapy.

THERANOSTICS (2021)

Article Gastroenterology & Hepatology

The role of hepatitis B core-related antigen in predicting hepatitis B virus recurrence after liver transplantation

Jiong Yu et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Biochemical Research Methods

Ultra-performance liquid chromatography-tandem mass spectrometry quantitative profiling of tryptophan metabolites in human plasma and its application to clinical study

Yun Chen et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)

Review Gastroenterology & Hepatology

Goals and targets for personalized therapy for HCC

Thomas Couri et al.

HEPATOLOGY INTERNATIONAL (2019)

Article Biotechnology & Applied Microbiology

Dimensionality reduction for visualizing single-cell data using UMAP

Etienne Becht et al.

NATURE BIOTECHNOLOGY (2019)

Article Cell Biology

Cytokines in Cancer Immunotherapy

Thomas A. Waldmann

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Article Biotechnology & Applied Microbiology

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Andrew Butler et al.

NATURE BIOTECHNOLOGY (2018)

Article Biochemical Research Methods

Mass cytometry analysis of immune cells in the brain

Ben Korin et al.

NATURE PROTOCOLS (2018)

Article Multidisciplinary Sciences

Massively parallel digital transcriptional profiling of single cells

Grace X. Y. Zheng et al.

NATURE COMMUNICATIONS (2017)

Article Pharmacology & Pharmacy

Modulation of Inflammation by Cicaderma Ointment Accelerates Skin Wound Healing

Christophe Morin et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)

Article Multidisciplinary Sciences

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Bin-Zhi Qian et al.

NATURE (2011)

Article Pharmacology & Pharmacy

Suppression of T-cell response and prolongation of allograft survival in a rat model by tryptophan catabolites

Xiangchen Dai et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2009)

Article Biochemical Research Methods

mRNA-Seq whole-transcriptome analysis of a single cell

Fuchou Tang et al.

NATURE METHODS (2009)

Review Oncology

The inflammatory chemokines CCL2 and CCL5 in breast cancer

Gali Soria et al.

CANCER LETTERS (2008)

Article Biochemistry & Molecular Biology

T cell apoptosis by tryptophan catabolism

I Fallarino et al.

CELL DEATH AND DIFFERENTIATION (2002)